Position statement on the use of biosimilars in inflammatory bowel disease.
Swiss Med Wkly
; 149: w20148, 2019 Dec 02.
Article
in En
| MEDLINE
| ID: mdl-31800086
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Inflammatory Bowel Diseases
/
Biosimilar Pharmaceuticals
Type of study:
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Swiss Med Wkly
Journal subject:
MEDICINA
Year:
2019
Document type:
Article
Affiliation country:
Switzerland
Country of publication:
Switzerland